Tiankang Bio (002100.SZ) issues profit warning, expecting a half-year net loss attributable to shareholders of 400 million to 520 million yuan.

Zhtng cijng APP xn, tin kng shngw (002100.SZ) fb 2026 nin bn nind yj ygo, gngs yj 2026 nin bn nind shxin gush y shngsh gngs gdng de jnglr wi kusn 4 y yun - 5.2 y yun, tngb yu yng zhun ku. App signal of Wisdom Financial News, Tiankang Biology (002100.SZ) announced its 2026 interim performance forecast, with the company expecting a net loss attributable to shareholders of the listed company of 4 billion to 5.2 billion yuan in the first half of 2026, turning from a profit to a loss year on year.